台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    60.9
  • 漲跌
    ▲1.2
  • 漲幅
    +2.01%
  • 成交量
    158
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 69人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
易威 (1799)籌碼相關-康和-內湖 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

康和-內湖 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/22160.5000.0060.9016040.17%
2025/01/20159.0000.0061.0016160.16%
2025/01/17358.9000.0058.6036160.49%
2025/01/15761.5400.0061.0076161.14%
2025/01/10165.6000.0065.4016240.16%
2024/12/26870.1300.0066.6086921.16%
2024/12/25774.2100.0074.0076831.02%
2024/12/20260.9000.0060.4026840.29%
2024/12/19963.2400.0062.7096951.29%
2024/12/12152.7000.0054.9016780.15%
2024/12/11155.4000.0054.9016660.15%
2024/12/09263.9000.0062.0026460.31%
2024/12/0400.000.166.7067.00-0.1655-0.02%
2024/11/26168.7000.0068.6016810.15%
2024/11/2100.000.167.8068.00-0.1662-0.02%
2024/11/1300.000.163.6064.00-0.1652-0.02%
2024/11/05288.1500.0084.9026360.31%
2024/11/04589.9600.0091.8056370.78%
2024/10/2900.00194.5096.40-1679-0.15%
2024/10/251101.001105.00100.0006870.00%
2024/10/181110.0000.00110.0017680.13%
2024/10/081.1124.8200.00126.001.18390.13%
2024/08/2900.001222.00221.00-1795-0.13%
2024/08/261228.0000.00226.0017900.13%
2024/08/2300.000.3228.00229.00-0.3798-0.04%
2024/08/1600.001195.00200.50-1822-0.12%
2024/08/151192.5000.00191.5018270.12%
2024/08/080.1186.0000.00187.000.17940.01%
2024/08/060.1176.0000.00171.000.17770.01%
2024/07/2900.001.2140.02141.50-1.2708-0.17%
2024/07/2600.000.2157.25148.00-0.2700-0.03%
2024/07/1600.001165.00174.50-1566-0.18%
2024/07/151160.5000.00164.5015540.18%
2024/07/1000.003152.50152.50-3512-0.58%
2024/07/034.4129.5600.00124.504.44740.93%
2024/05/2800.002101.00100.00-2312-0.64%
2024/05/272100.251100.50100.0013070.33%
2024/05/24199.5000.00105.0012980.33%
2024/05/2300.00295.00100.50-2286-0.70%
2024/05/22293.10295.0091.5002600.00%
2024/05/21291.4500.0093.0022500.80%
2024/03/0800.00159.1061.00-1214-0.47%
2024/03/0500.00563.6064.00-5200-2.49%
2024/03/04560.000.155.1060.204.91932.52%
2024/02/2900.000.754.5054.60-0.7180-0.39%
2024/02/1500.000.152.7855.50-0.1177-0.06%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音